Specifications TableSubject*Toxicology*Specific subject area*Air pollutant and Toxicology*Type of data*Table and Figure*How data were acquired*Sampling method: Active sampling of PM 2.5 using Dichtomous Sampler (Model 241, Rupprecnt and Patashrick manufactured), and Software model: MPPD version 2.1 software was downloaded* via <http://www.ara.com/products/mppd.htm>*. to estimate the regional particles deposition in respiratory tract and retention in the respiratory tract*Data format*Raw and graph*Parameters for data collection*tracheobronchial fluid used for this work was formulated using recipe partially substituted with locus bean, bioaccessibility of particulate matters-bound trace elements were analyzed*Description of data collection*Formulation of tracheobronchial fluid, bioaccessibility, exposure dose and lung deposition*Data source location*Ado -Ekiti, Ekiti State, Nigeria* (*Longitude 5.150*^*0*^*E, Latitude 7.100*^*0*^*N)*Data accessibility*The raw data files are archived in FUOYE Repository*<http://repository.fuoye.edu.ng/handle/123456789/2251>\
*Data is available from the corresponding author upon reasonable request.*Related research article*E.G Olumayede* et al. *"Development of tracheobronchial fluid, in vitro bioaccessibility assessment of particulates-bound trace elements. MethodsX 6 (2019) 1944--1949* \[[@bib1]\]**Value of the Data**•Data in this article format can be explored in risks assessment of exposure to inhale particulate matters in the area•The data can be used for inter-laboratory comparison of bioaccessibility of element-bound particulates•The data generated could stimulate environmental concerns on the impacts of airborne particulates•The data could be translated into improved respiratory health among the people exposed to ambient particulate matters.

1. Data {#sec1}
=======

The dataset in this article describes the bioaccessibility of elements-bound airborne particulates collected in selected locations of Ado -- Ekiti, an urban center in Southwest, Nigeria using modeled tracheobronchial fluid. [Table 1](#tbl1){ref-type="table"} describes the recepies of the modeled tracheobronchial fluid in which locally avaliable materials as substituent. [Fig. 1](#fig1){ref-type="fig"} describes bioaccessibility *in vitro* extraction test of the various metals at different sites of the data collection locations using the formulation. [Fig. 2](#fig2){ref-type="fig"} displays the estimated regional particles deposition in respiratory tract using MPPD version 2.1 software.Table 1Recipe for synthetic tracheobronchial fluid.Table 1ReagentConcentration (mg/L)InorganicNaCl6020Cacl~2~.2H~2~O256Na~2~HPO~4~150NaHCO~3~2700KCl298MgCl~2~200Na~2~SO~4~72SurfactantDPPC100Thickening agentLocus beans gum350Chelating agentCitrate50Large-Molecular mass ProteinAlbumin260Cross-linking agentpolyethylene oxide resins500AntioxidantAscorbic acid18Organic acidsGlycine376Cysteine122[^1]Fig. 1Bioaccessibility (%) of the various metals at different sites of the data collection locations using tracheobronchial airway fluid. Navy Blue, red, green, purple and light blue represent Fajuyi, Oja-Oba, Secretariat, Ilokun and Poly Road sites respectively.Fig. 1Fig. 2Deposition fractions of various metals in regions of human respiratory tract. Blue, Red and Green bars represent deposited fractions in the respiratory tract.Fig. 2

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Formulation and preparation of tracheobronchial fluid {#sec2.1}
----------------------------------------------------------

The recipe of formulated fluid used for this work was described in previous works \[[@bib1],[@bib2]\], where Gambles' solution was modified \[[@bib3],[@bib4]\] and used in *in vitro* extractions and to evaluate bioaccessibility \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11]\] of some elements in healthy non-smoking human. The compositions of the fluid contain Inorganic and organic constituents mixed in ultra-pure water. The modifications to the fluid in this work include the use of locus beans gum, as thickening agent and addition of weak chelating agent (citrate) and antioxidant (Ascorbic acid). Furthermore, polyethylene oxide resin was used to replace mucin, as crosslinking agent, due to their availability.

2.2. Description of data collection center {#sec2.2}
------------------------------------------

The data collection center for this article is Ado -- Ekiti, the administrative headquarter of Ekiti state, southwest Nigeria and lies on Longitude 5.150^0^E, Latitude 7.100^0^N. It is a fast growing urban settlement that has witnessed tremendous growth resulting from rural-urban migration into the city since it was named as the capital city of the Ekit state in 1996. According to population census of 2006 report, Ado - Ekiti has about 484,798 inhabitants \[[@bib12]\], and by now should be close to 1 million. The city is impacted by particulate matters from anthropogenic activities; such as traffic, open burning of waste, aerosols from unpaved roads and construction works.

2.3. Sampling of airborne particulates matters over Ado - Ekiti {#sec2.3}
---------------------------------------------------------------

Samples of airborne particulates were collected in five (5) selected sites of Ado - Ekiti city using a Dichtomous Sampler (Model 241, Rupprecnt and Patashrick manufactured) at 2-week intervals for 5 months from November 2016 to March 2017 at height of 1.5--2 m. Five sampling sites were carefully chosen within the city, to reflect different human activities impacting the environments. The sampler consists of an omnidirectional aerosol inlet and a virtual impactor assembly along with tripod stand. It collects particles in two size ranges; d \< 2.5 μm and 2.5 \< d \< 10μm, which are collected on two separate PTFE Teflon (37mm diameter) filters. The sampler operates at a flow rate of 16.7Lmin^−1^for 2 hours. For each sampling, the filters were equilibrated in a charged desiccator for 24 hours and weighed before and after sampling. After weighing, particulates were stored in a refrigerator at 4 °C until analysis. A total of 15 samples were collected in each site during sampling period of this work. The samples were then prepared for elemental analysis and bioaccessibility test.

2.4. Bioaccessible fraction of elements bound to particulate matters {#sec2.4}
--------------------------------------------------------------------

Bioaccessibile of elements bound to airborne particulates collected at different locations were determined in *in vitro* extraction test. For the purpose of this dataset, we used PM~2.5~ particle size only. Samples were placed into five different a 15-ml polypropylene centrifuge tube, with 0.25g of particulates per tube. Each sample was mixed with 10 ml of formulated tracheobronchial fluid, and the tube was made airtight and immersed for 2 h in a shaking water bath at 37 °C (1-h shaking followed by 1 h still). The obtained extractants were cooled to room temperature, then centrifuged for 20 min at 3500 rpm and separated for element determination. The bioaccessibility (%) was determined as the soluble fraction of an element in PM that dissolved in tracheobronchial fluid \[[@bib9]\].

2.5. Modeling exposure and lung deposited doses {#sec2.5}
-----------------------------------------------

The amount of airborne particulates intake via inhalation exposure pathway is computed as described in previous article \[[@bib13]\]. Multiple-path particle deposition (MPPD) mathematical model \[[@bib14],[@bib15]\] was employed to estimate deposition of elements in different regionals of the lung (alveolar, trachea-bronchial and extra thoracic) in children and adults. The MPPD version 2.1 software was downloaded via <http://www.ara.com/products/mppd.htm>. The human airway morphometric model selected for this dataset was the Yeh/Schum symmetric. Other parameters chosen for the dataset include inhalant properties (aerosol), Breathing scenario (endotracheal); time (1), mass concentration (1 mgm^−3^), Breathing frequency (120 1/min), and tidal volume (625 ml). The data input includes size of the particulate (Count medium diameter, CMD) \[[@bib16]\].$$Inhalability = 1 - \left\lbrack \left. 1 + e^{({13.56 + 0.4343})}X\ \log\ dae\quad - 4.88 \right) \right\rbrack^{- 1}$$where, d~ae~ (μm) is the aerodynamic particle diameter.
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[^1]: DPPC means dipalmitoylphophatidylcholine.
